Sharon Bio-Medicine Limited is a Indian Pharmaceutical, Company listed at Bombay Stock Exchange. Over the years it has evolved from being a manufacturer of Intermediates & Active to now providing a range of Pharmaceutical products & services including Animal Toxicology and Manufacturing of Finished Dosages
Sharon was predominantly been known for its strengths in development & manufacturing of Pharmaceutical Intermediates & Actives. In 2007 with a focus on high quality standards Sharon ventured into the Finished product segment set up a Oral Solid dosage manufacturing facility at Dehradoon, India and later complimented its strategy by setting up an GMP compliant API Facility near Mumbai. With European regulatory approvals for two of its manufacturing facilities the long term benefits of an integrated business model (API+Finished Products) are now being realized
Sharon’s long term focus is to be an integrated service provider for its customers & adding competitive advantage to its customer’s products throughout its life cycle.
Services offered are:
- Preclinical Toxicology on small animals
- Chemical Process Development & Scale up
- Formulation Development
- Analytical Method Development
- DMF & Dossier preparation. (Sharon also undertakes joint development projects for ANDA & CTD Dossiers.)
- Commercial Manufacturing of Intermediates, Actives, Finished Dosages.
- Stability monitoring for the entire shelf life of the product.